{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:36:10Z","timestamp":1794670570825,"version":"4.9.1"},"reference-count":15,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"vor","delay-in-days":3550,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A retrospective study of 531 leprosy patients was undertaken to study the profile of reactions in the post Multi\u2010Drug\u2010Therapy period in a tertiary hospital in Delhi. BT was the most common group. The prevalence of reactions was found to be 8.09% for the Type 1 and 4.70% for the Type 2 reactions for a male:female ratio of 2.2. The Type 1 reaction was most frequently observed in the BB group followed by BL, BT and LL groups respectively. More than half of the patients had reactions at the time of presentation. In only 39.8% of the patients did reaction follow Multi\u2010Drug\u2010Therapy. In 4.5% of the patients with Type 1 reactions (T1R), concomitant infections were noted. The most common presentation of T1R was cutaneous lesions (74.41%) followed by cutaneous lesions and neuritis (53.6%), neuritis alone (12.1%), and only edema of hands and feet (7.31%) respectively. The Type 2 reactions (T2R) presented chiefly as papulo\u2010nodular (92%) lesions followed by pustulonecrotic (8%) lesions. Associated neuritis was found in 40% and periosteitis and iritis in 8% and 4%, respectively. In 8.6% of the patients with T2R, precipitating factors could be observed. The prevalence of deformities in patients with reaction was 25%, and was more common in females. Deformities were observed in 23.25% of the T1R patients and 28% of the T2R patients.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2004.tb00623.x","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T09:43:38Z","timestamp":1406022218000},"page":"898-903","source":"Crossref","is-referenced-by-count":21,"title":["A Study of Leprosy Reactions in a Tertiary Hospital in Delhi"],"prefix":"10.1111","volume":"31","author":[{"given":"Neelu","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Dermatology &amp; Sexually Transmitted Diseases Lady Hardinge Medical College &amp; S.S.K. and K.S.C. Hospitals  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra V.","family":"Koranne","sequence":"additional","affiliation":[{"name":"Department of Dermatology &amp; Sexually Transmitted Diseases Lady Hardinge Medical College &amp; S.S.K. and K.S.C. Hospitals  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhu","family":"Mendiratta","sequence":"additional","affiliation":[{"name":"Department of Dermatology &amp; Sexually Transmitted Diseases Lady Hardinge Medical College &amp; S.S.K. and K.S.C. Hospitals  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Chandra","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Dermatology &amp; Sexually Transmitted Diseases Lady Hardinge Medical College &amp; S.S.K. and K.S.C. Hospitals  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.5935\/0305-7518.19940002"},{"key":"e_1_2_5_3_1","volume-title":"Chemotherapy of Leprosy for Control Programmes","author":"World Health Organisation Study Group","year":"1982"},{"key":"e_1_2_5_4_1","first-page":"559","article-title":"Epidemiologic characterics of leprosy reactions","volume":"62","author":"Scollard DM","year":"1994","journal-title":"International Journal of Leprosy"},{"key":"e_1_2_5_5_1","first-page":"255","article-title":"Classification of leprosy according to immunity; A five group system","volume":"34","author":"Ridley DS","year":"1996","journal-title":"International Journal of Leprosy"},{"key":"e_1_2_5_6_1","volume-title":"Chemotherapy of Leprosy for Control Programmes","author":"World Health Organisation Study Group","year":"1994"},{"key":"e_1_2_5_7_1","volume-title":"World Health Organisation Expert Committee on Leprosy","year":"1988"},{"key":"e_1_2_5_8_1","first-page":"18","article-title":"Incidence of late lepra reaction among multibacillary leprosy patients after MDT","volume":"63","author":"Vijayakumaran P","year":"1995","journal-title":"Int J Dermatol"},{"key":"e_1_2_5_9_1","first-page":"161","article-title":"A Clinico\u2010epidemiological study of leprosy in arid North\u2010West Jodhpur","volume":"67","author":"Sallodkar AD","year":"1995","journal-title":"Indian J Dermatol"},{"key":"e_1_2_5_10_1","first-page":"190","article-title":"Reactions in Leprosy; An epidemiological study of 356 patients in West\u2010Nepal","volume":"65","author":"Brakel WHV","year":"1994","journal-title":"Leprosy Review"},{"key":"e_1_2_5_11_1","first-page":"227","article-title":"Retrospective analysis of 194 leprosy patients in the Republic of Yemen","volume":"68","author":"Meklafi GA","year":"1996","journal-title":"Indian J Dermatol"},{"key":"e_1_2_5_12_1","first-page":"450","article-title":"Risk factors for type I reactions in leprosy","volume":"65","author":"Roche PW","year":"1997","journal-title":"Int J Dermatol"},{"key":"e_1_2_5_13_1","first-page":"275","volume-title":"Leprosy","author":"Pfaltzgraff RE","year":"1994"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.5935\/0305-7518.19910013"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.5935\/0305-7518.19690026"},{"key":"e_1_2_5_16_1","first-page":"270","article-title":"Risk factors for erythema nodosum leprosum","volume":"67","author":"Manandhar R","year":"1999","journal-title":"Int J Leprosy"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2004.tb00623.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2004.tb00623.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T01:27:13Z","timestamp":1700184433000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2004.tb00623.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1111\/j.1346-8138.2004.tb00623.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2004.tb00623.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}